Loading
IARC estimates 20,402 new cancer cases and 12,710 cancer deaths in Côte d'Ivoire in 2024; the commonest new cancers are breast, prostate and cervix uteri. This page is assembled automatically from OnCo's data: 1 trial with a site there, and says what OnCo does not yet hold.
| Site | New cases | Rate | OnCo page |
|---|---|---|---|
| Breast | 4,845 | 48.1 | Triple-negative breast cancer (TNBC), HR-positive / HER2-negative breast cancer, HER2-positive breast cancer |
| Prostate | 2,632 | 41.7 | Prostate cancer |
| Cervix uteri | 2,540 | 29.6 | Cervical cancer |
| Liver and intrahepatic bile ducts | 1,696 | 9.1 | Hepatocellular carcinoma |
| Colorectum | 1,132 | 6.9 | Colorectal cancer |
| Non-Hodgkin lymphoma | 770 | 3.1 | Non-Hodgkin lymphoma (all types), Diffuse large B-cell lymphoma |
| Stomach | 513 | 3.2 | Gastric & gastro-oesophageal junction cancer |
| Pancreas | 430 | 2.8 | Pancreatic ductal adenocarcinoma |
| Ovary | 393 | 4.4 | Ovarian cancer |
| Corpus uteri | 308 | 4.3 | Endometrial cancer |
| Site | Deaths | Rate | OnCo page |
|---|---|---|---|
| Breast | 2,284 | 24.1 | Triple-negative breast cancer (TNBC), HR-positive / HER2-negative breast cancer, HER2-positive breast cancer |
| Prostate | 1,605 | 25.7 | Prostate cancer |
| Cervix uteri | 1,542 | 18.6 | Cervical cancer |
| Liver and intrahepatic bile ducts | 1,515 | 8.3 | Hepatocellular carcinoma |
| Colorectum | 650 | 4.2 | Colorectal cancer |
| Pancreas | 409 | 2.7 | Pancreatic ductal adenocarcinoma |
| Stomach | 393 | 2.6 | Gastric & gastro-oesophageal junction cancer |
| Non-Hodgkin lymphoma | 346 | 1.6 | Non-Hodgkin lymphoma (all types), Diffuse large B-cell lymphoma |
| Ovary | 264 | 3.2 | Ovarian cancer |
| Trachea, bronchus and lung | 205 | 1.3 | Lung cancer (all types), Non-small-cell lung cancer, Small-cell lung cancer |
| Trial | Lead sponsor | ||||
|---|---|---|---|---|---|
| Phase 3 | Active not recruiting | Hoffmann-La Roche | 171 | 2025-12-31 |
Trial records in OnCo whose ClinicalTrials.gov entry lists at least one site in Côte d'Ivoire, captured 2026-10-07 to 2026-10-07. Recruiting first, then the most recently updated. The status is the study's overall status; whether a site in Côte d'Ivoire is open is on the registry page, under Contacts and Locations.
OnCo holds no institution, company or person in Côte d'Ivoire.
OnCo records approvals for United States, European Union, United Kingdom, Japan, China, Australia and India. Côte d'Ivoire is not one of them, so no approval in OnCo speaks for it. See the approvals by region matrix for what is held.
Côte d'Ivoire is not among the 60 countries ranked in the country coverage queue (November 2026), which ranks countries without a page by cases, deaths, research output and population. Know a source? Suggest an edit.